Thomas A. Satterfield, Jr.

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

Stocks Covered

Latest Filing

Feb 5, 2026

Filings

ALCO

Alico, Inc.

SC 13G/A · Feb 5, 2026

6.4%

487K shares

NVNO

enVVeno Medical Corporation

SC 13G · Nov 19, 2025

9.0%

1.8M shares

BCDA

BioCardia, Inc.

SC 13G/A · Aug 13, 2025

9.9%

592K shares

OSTX

OS Therapies Incorporated

SC 13G/A · Aug 13, 2025

9.4%

3.1M shares

ARKR

Ark Restaurants Corp.

SC 13G/A · Aug 7, 2025

17.3%

622K shares

INTT

inTest Corporation

SC 13G/A · Aug 7, 2025

8.0%

1.0M shares

CHRS

Coherus BioSciences, Inc.

SC 13G · Apr 16, 2025

5.2%

6.0M shares

CRIS

Curis, Inc.

SC 13G/A · Apr 16, 2025

9.9%

1.0M shares

EDSA

Edesa Biotech, Inc.

SC 13G/A · Feb 18, 2025

0.0%

0 shares

OSTX

OS Therapies Incorporated

SC 13G/A · Feb 12, 2025

5.9%

1.3M shares

INTT

inTEST Corporation

SC 13G/A · Feb 12, 2025

6.5%

805K shares

ARKR

ARK RESTAURANTS CORP.

SC 13G/A · Feb 12, 2025

15.9%

574K shares

N/A

Scientific Industries, Inc.

SC 13G/A · Feb 12, 2025

9.9%

1.1M shares

EDSA

Edesa Biotech, Inc.

SC 13G/A · Feb 12, 2025

6.7%

232K shares

CRIS

Curis, Inc.

SC 13G/A · Feb 12, 2025

9.1%

790K shares

BCDA

BioCardia, Inc.

SC 13G/A · Feb 12, 2025

8.2%

388K shares

CTSO

CytoSorbents Corporation

SC 13G · Jan 17, 2025

6.6%

4.0M shares

BCDA

SC 13G 1 d537082dsc13g.htm SC 13G SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 BioCardia, Inc.

SC 13G · Aug 7, 2023

5.6%

1.1M shares

SFES

Safeguard Scientifics, Inc.

SC 13G/A · Feb 10, 2023

11.4%

1.9M shares

ARKR

Ark Restaurants Corp.

SC 13G/A · Feb 10, 2023

15.3%